✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Proflavine is an investigational drug.
There have been 16 clinical trials for Proflavine. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2014.
The most common disease conditions in clinical trials are Neoplasms, Barrett Esophagus, and Uterine Cervical Neoplasms. The leading clinical trial sponsors are M.D. Anderson Cancer Center, Anandasabapathy, Sharmila, M.D., and William Marsh Rice University.
There are two hundred and sixty-nine US patents protecting this investigational drug and nine international patents.
Recent Clinical Trials for Proflavine
|Acceptability and Performance of a Mobile Optical Biopsy Technology for Gastrointestinal Cancer Screening||Baylor College of Medicine||Phase 2|
|Acceptability and Performance of a Mobile Optical Biopsy Technology for Gastrointestinal Cancer Screening||University of Sao Paulo||Phase 2|
|Acceptability and Performance of a Mobile Optical Biopsy Technology for Gastrointestinal Cancer Screening||William Marsh Rice University||Phase 2|
Top disease conditions for Proflavine
Top clinical trial sponsors for Proflavine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Proflavine||See Plans and Pricing||Methods and devices for minimally-invasive delivery of radiation to the eye||Salutaris Medical Devices, Inc. (Tucson, AZ)||See Plans and Pricing|
|Proflavine||See Plans and Pricing||Synergistic compositions for treating microbial infections||University of Rochester (Rochester, NY) Temple University--Of the Commonwealth System of Higher Education (Philadelphia, PA)||See Plans and Pricing|
|Proflavine||See Plans and Pricing||Strip package for antiseptic cap||Excelsior Medical Corporation (San Clemente, CA)||See Plans and Pricing|
|Proflavine||See Plans and Pricing||Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid||MERCK & CIE (Schaffhausen, CH)||See Plans and Pricing|
|Proflavine||See Plans and Pricing||Amylases, nucleic acids encoding them and method of producing an oil||BASF ENZYMES LLC (San Diego, CA)||See Plans and Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Proflavine||China||CN107208158||2035-02-27||See Plans and Pricing|
|Proflavine||European Patent Office||EP3262192||2035-02-27||See Plans and Pricing|
|Proflavine||Spain||ES2836802||2035-02-27||See Plans and Pricing|
|Proflavine||World Intellectual Property Organization (WIPO)||WO2016138496||2035-02-27||See Plans and Pricing|
|Proflavine||Australia||AU2018289077||2037-06-23||See Plans and Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|